Literature DB >> 30194470

[Human papillomavirus disease burden in men : HPV prevention is a man's business].

P Schneede1.   

Abstract

Due to the lack of an established school-based immunization program, the initial German public funded girls-only human papillomavirus (HPV)-vaccination strategy failed. Over the last decade, the female coverage rates have not exceeded much more than 40%, thus, missing herd immunity for boys. Therefore, the German HPV immunization program has been revised and currently recommends a gender-neutral HPV vaccination for all children aged 9-14 years to prevent all HPV-related tumors which can be prevented by immunization. In order to correct the mistaken German impression of this being an  issue relevant only to females, this article highlights the HPV disease burden in men which mostly can be prevented by timely immunization of boys. German urologists have started a campaign: HPV prevention is a man's business.

Entities:  

Keywords:  Anogenital warts; Cancer vaccines; Cervical cancer; Oropharyngeal cancer; Populations at risk

Mesh:

Substances:

Year:  2018        PMID: 30194470     DOI: 10.1007/s00120-018-0770-8

Source DB:  PubMed          Journal:  Urologe A        ISSN: 0340-2592            Impact factor:   0.639


  17 in total

1.  [Proven and new methods in the treatment of genital warts].

Authors:  P Schneede; R Waidelich
Journal:  Urologe A       Date:  2013-10       Impact factor: 0.639

2.  [Urethral condylomas. A therapeutic challenge].

Authors:  P Schneede; P Münch; F Ziller; A Hofstetter
Journal:  Hautarzt       Date:  2001-05       Impact factor: 0.751

3.  S2k-Leitlinie: HPV-assoziierte Läsionen der äußeren Genitalregion und des Anus - Genitalwarzen und Krebsvorstufen der Vulva, des Penis und der peri- und intraanalen Haut (Kurzfassung).

Authors:  Gerd E Gross; Ricardo N Werner; Jürgen C Becker; Norbert H Brockmeyer; Stefan Esser; Monika Hampl; Sara Hommel; Johannes Jongen; Dominik S Mestel; Thomas Meyer; Karl U Petry; Andreas Plettenberg; Klaus Püschel; Peter Schneede; Helmut Schöfer; Karl Sotlar; Gerhard Weyandt; Ulrike Wieland; Miriam Wiese-Posselt; Alexander Nast
Journal:  J Dtsch Dermatol Ges       Date:  2018-02       Impact factor: 5.584

4.  Fall in genital warts diagnoses in the general and indigenous Australian population following implementation of a national human papillomavirus vaccination program: analysis of routinely collected national hospital data.

Authors:  Megan A Smith; Bette Liu; Peter McIntyre; Robert Menzies; Aditi Dey; Karen Canfell
Journal:  J Infect Dis       Date:  2014-08-12       Impact factor: 5.226

Review 5.  [One decade of HPV vaccination in Germany].

Authors:  P Schneede
Journal:  Urologe A       Date:  2017-06       Impact factor: 0.639

6.  [Condylomata acuminata: an indication for prophylactic HPV vaccination?].

Authors:  P Schneede; B Schlenker; E Hungerhuber
Journal:  Urologe A       Date:  2006-12       Impact factor: 0.639

7.  Recurrence of condylomata acuminata of the urethra after conventional and fluorescence-controlled Nd:YAG laser treatment.

Authors:  D Zaak; A Hofstetter; D Frimberger; P Schneede
Journal:  Urology       Date:  2003-05       Impact factor: 2.649

Review 8.  Economic burden of non-cervical cancers attributable to human papillomavirus: a European scoping review.

Authors:  Emmanuelle Préaud; Nathalie Largeron
Journal:  J Med Econ       Date:  2013-04-24       Impact factor: 2.448

9.  Incidence of anogenital warts in Germany: a population-based cohort study.

Authors:  Angela A Kraut; Tania Schink; Renate Schulze-Rath; Rafael T Mikolajczyk; Edeltraut Garbe
Journal:  BMC Infect Dis       Date:  2010-12-23       Impact factor: 3.090

10.  Decline in in-patient treatments of genital warts among young Australians following the national HPV vaccination program.

Authors:  Hammad Ali; Rebecca J Guy; Handan Wand; Tim Rh Read; David G Regan; Andrew E Grulich; Christopher K Fairley; Basil Donovan
Journal:  BMC Infect Dis       Date:  2013-03-18       Impact factor: 3.090

View more
  1 in total

1.  [Improvement of vaccination activities in urology].

Authors:  Peter Schneede
Journal:  Urologe A       Date:  2019-11       Impact factor: 0.639

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.